Vienna / Rengsdorf / Newmarket, April 2, 2025 – Effective March 31,Lohmann & Rauscher Group (L&R) acquired Unisurge International Ltd., the UK’s market-leading and renowned manufacturer and supplier of medical Custom Procedure Packs (CPTs) and further OR products with sites in Newmarket (headquarters) and Castleford. With this strategic acquisition, L&R Group secures market access to the hospital sector and surgical products in the UK. Unisurge will remain an independent company within the L&R Group, a leading, internationally active private company for medical devices and services with roots in Germany and Austria. Current Unisurge CEO Amir Farboud will continue to lead the company and all jobs at Unisurge will be retained. The acquisition is part of L&R’s growth strategy, which intensifies the focus on strategic mergers & acquisitions.
Unisurge was founded in 1988 and reimagined in 2004, then pioneering the surgical Custom Procedure Pack (CPTs) market in the UK. It manufactures and supplies CPTs, surgical drapes, surgical instruments and further products. The company has established a strong reputation in the medical industry, providing high-quality products that meet the stringent demands of healthcare professionals in the hospital sector of UK, especially at the NHS. Unisurge employs in total more than 280 staff in Newmarket (headquarters, with about 249 employees) and Castleford (32 employees), who work in administration, production, logistics (including the company’s own fleet) and direct sales. The company has been able to record growing market share in recent years resulting in a turnover of 48.5 million pounds in 2024.
The L&R Group is a leading, internationally active private company, with roots and headquarters in Germany and Austria, specializing in the development, manufacturing and global sale of medical devices and hygiene products and services. The company is focused on solutions for wound care, including negative pressure wound therapy, compression products and systems, and OR products. With today more than 5,600 employees worldwide, more than 50 subsidiaries, and shareholdings in 28 countries, along with more than 140 selected distribution partners, L&R is present in all major markets around the globe. In 2024, L&R achieved a sales volume of approximately 813 million euros.
The post-acquisition phase will be characterized by continuity: Unisurge will still operate under its current name as a subsidiary of L&R with an independent brand.
Current Unisurge CEO Amir Farboud will continue to lead the business. All jobs at Unisurge will be retained. This decision underscores L&R’s dedication to maintaining the strengths and culture of the Unisurge team while fostering collaboration and growth.
The British sales subsidiary of the L&R Group, L&R Medical UK Ltd. will not be involved in the OR business. L&R Medical UK Ltd. is located in Burton upon Trent (Staffordshire) and will continue to focus on solutions for wound care and compression therapy as they do today.
With this acquisition, effective March 31, 2025, the L&R Group secures market access to the hospital sector and surgical products in the UK. It will enhance the Group’s product portfolio and strengthen its position in the UK market and in the European OR product market. This strategic move aligns with its corporate strategy, which emphasizes growth through strategic mergers and acquisitions as one of the key drivers for future expansion.
Joint Statement from L&R CEO & COO Thomas Menitz and CFO Holger Mägdefrau:
“The Unisurge team have done a very good and successful job in the past years and we are thrilled to welcome Unisurge and all the colleagues to the L&R family. This acquisition represents a significant milestone in our company strategy as it is one of the largest acquisition in the history of the group. Since we are both family businesses, we are convinced that our common path will be characterized by mutual understanding and solidarity – and of course success. Combining our strengths, we look forward to delivering exceptional value and service to our customers in the UK.”
Quote from Amir Farboud, CEO of Unisurge:
“We are very excited to join the L&R Group, a company that shares our commitment to customer focus, quality and reliability. Being part of L&R will enable us to leverage L&R’s global expertise and resources while continuing to operate as an independent, well-known and trusted partner for our customers. Our employees are the backbone of our success, and we are pleased that L&R recognizes and values their contributions. Together, we will continue to provide outstanding products and services to the NHS and our further customers.”
About Lohmann & Rauscher:
Lohmann & Rauscher Group
Lohmann & Rauscher (L&R) is a leading international developer, manufacturer and supplier of high quality, future-oriented medical devices and hygiene products – ranging from conventional bandages to modern treatment and nursing systems. Created in 1998 from the merger of the two companies Lohmann (founded in 1851) and Rauscher (founded in 1899), L&R has more than 170 years of expertise as a dependable partner and solution provider for its customers.
With more than 5,600 employees, more than 50 subsidiaries and shareholdings, as well as more than 140 selected distribution partners in 120 countries, L&R is represented in all important markets around the world and was able to realize a sales volume of 812,7 million euros in 2024. The company’s headquarters are located at the Rengsdorf (Germany) and Vienna (Austria) sites.
The entrepreneurial spirit of L&R reflects in the corporate claim: People.Health.Care. – the human, the health and the care for both.
More information on Lohmann & Rauscher (L&R) at:
www.lohmann-rauscher.com
About Unisurge International Ltd.:
Unisurge International Ltd. is a market-leading manufacturer and supplier of Custom Procedure Packs (CPTs), disposable surgical products, surgical instruments, laparoscopic instruments, ward sets, and gauze bandages. Known for its “Formula” brand, Unisurge has built a strong reputation for quality in the medical industry. The company was founded in 1988 by John Farboud and reimagined in 2004, pioneering the Custom Procedure Pack market in the UK.
